LSB Industries, Inc. Schedules 2026 Third Quarter Results Release for Wednesday, October 28th and Conference Call for Thursday, October 29thBusiness Wire · Oct 14, 2026
LSB Industries, Inc. to Participate in Upcoming Investor ConferencesBusiness Wire · Sep 1, 2026
LSB Industries: Why Cost Advantage Makes It A BuySeeking Alpha · Aug 16, 2026
LSB Industries, Inc. Reports Operating Results for the 2026 Second QuarterBusiness Wire · Jul 29, 2026LakeShore Biopharma Co., Ltd is a biopharmaceutical firm focused on the discovery, advancement, manufacturing, and marketing of vaccines and therapeutic biologics. Its primary targets are infectious diseases and various forms of cancer. At the core of its innovation is a proprietary PIKA immunomodulating technology platform, which underpins its product pipeline, featuring a PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.